Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: A comparative study between methylprednisolone versus dexamethasone as an initial anti-inflammatory treatment of moderate COVID-19 pneumonia: an open-label randomized controlled trial

Fig. 2

Diagram of the mean (95% confidence interval) of WHO clinical progression scales at day 1, day 5, and day 10 in the MP group and DXM group and p-value by multilevel mixed-effects linear regression. Data are presented as mean (95% confidence interval or 95%CI) and p-value. MP: methylprednisolone; DXM: dexamethasone

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us